drugset / Trial / NCT00318084

PPI Test in GP Patients

NCT00318084

Phase 4 Completed 100 enrolled AstraZeneca UMC Utrecht · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the diagnostic value of two week treatment with Nexium as a confirmatory test for patients with suspected reflux disease.

Timeline

Start
2003-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule